A multifaceted biomimetic interface to improve the longevity of orthopedic implants.

Bone integration Bone morphogenetic proteins Metal 3D printing Multi-functional biomaterials Plasma polymer films Scaffolds

Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 18 02 2020
revised: 23 03 2020
accepted: 09 04 2020
pubmed: 29 4 2020
medline: 15 5 2021
entrez: 29 4 2020
Statut: ppublish

Résumé

The rise of additive manufacturing has provided a paradigm shift in the fabrication of precise, patient-specific implants that replicate the physical properties of native bone. However, eliciting an optimal biological response from such materials for rapid bone integration remains a challenge. Here we propose for the first time a one-step ion-assisted plasma polymerization process to create bio-functional 3D printed titanium (Ti) implants that offer rapid bone integration. Using selective laser melting, porous Ti implants with enhanced bone-mimicking mechanical properties were fabricated. The implants were functionalized uniformly with a highly reactive, radical-rich polymeric coating generated using a unique combination of plasma polymerization and plasma immersion ion implantation. We demonstrated the performance of such activated Ti implants with a focus on the coating's homogeneity, stability, and biological functionality. It was shown that the optimized coating was highly robust and possessed superb physico-chemical stability in a corrosive physiological solution. The plasma activated coating was cytocompatible and non-immunogenic; and through its high reactivity, it allowed for easy, one-step covalent immobilization of functional biomolecules in the absence of solvents or chemicals. The activated Ti implants bio-functionalized with bone morphogenetic protein 2 (BMP-2) showed a reduced protein desorption and a more sustained osteoblast response both in vitro and in vivo compared to implants modified through conventional physisorption of BMP-2. The versatile new approach presented here will enable the development of bio-functionalized additively manufactured implants that are patient-specific and offer improved integration with host tissue. STATEMENT OF SIGNIFICANCE: Additive manufacturing has revolutionized the fabrication of patient-specific orthopedic implants. Although such 3D printed implants can show desirable mechanical and mass transport properties, they often require surface bio-functionalities to enable control over the biological response. Surface covalent immobilization of bioactive molecules is a viable approach to achieve this. Here we report the development of additively manufactured titanium implants that precisely replicate the physical properties of native bone and are bio-functionalized in a simple, reagent-free step. Our results show that covalent attachment of bone-related growth factors through ion-assisted plasma polymerized interlayers circumvents their desorption in physiological solution and significantly improves the bone induction by the implants both in vitro and in vivo.

Identifiants

pubmed: 32344174
pii: S1742-7061(20)30217-8
doi: 10.1016/j.actbio.2020.04.020
pii:
doi:

Substances chimiques

Titanium D1JT611TNE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

266-279

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Michiel Croes (M)

Department of Orthopedics, University Medical Center Utrecht, Utrecht 3508GA, the Netherlands.

Behnam Akhavan (B)

School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia; School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia. Electronic address: behnam.akhavan@sydney.edu.au.

Omid Sharifahmadian (O)

School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia.

Haiyang Fan (H)

PMA, Department of Mechanical Engineering, KU Leuven & Member of Flanders Make, Celestijnenlaan 300, Leuven B-3001, Belgium.

Raya Mertens (R)

PMA, Department of Mechanical Engineering, KU Leuven & Member of Flanders Make, Celestijnenlaan 300, Leuven B-3001, Belgium.

Richard P Tan (RP)

School of Medical Sciences, Dept of Phsyiology, University of Sydney, NSW 2006, Australia; Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia.

Aliza Chunara (A)

School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia; School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia.

Arifah A Fadzil (AA)

School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia; School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia.

Steven G Wise (SG)

School of Medical Sciences, Dept of Phsyiology, University of Sydney, NSW 2006, Australia; Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia.

Moyo C Kruyt (MC)

Department of Orthopedics, University Medical Center Utrecht, Utrecht 3508GA, the Netherlands.

Sebastiaan Wijdicks (S)

Department of Orthopedics, University Medical Center Utrecht, Utrecht 3508GA, the Netherlands.

Wim E Hennink (WE)

Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht 3512JE, the Netherlands.

Marcela M M Bilek (MMM)

School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia; School of Physics, University of Sydney, Sydney, New South Wales 2006, Australia; Charles Perkins Centre, University of Sydney, Sydney, New South Wales 2006, Australia; Sydney Nano Institute, University of Sydney, Sydney, New South Wales 2006, Australia.

Saber Amin Yavari (S)

Department of Orthopedics, University Medical Center Utrecht, Utrecht 3508GA, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH